| A nanoprimer to improve the systemic delivery of siRNA and mRNA NRM Saunders, MS Paolini, OS Fenton, L Poul, J Devalliere, F Mpambani, ... Nano Letters 20 (6), 4264-4269, 2020 | 55 | 2020 |
| β‐Aminoacrylate Synthetic Hydrogels: Easily Accessible and Operationally Simple Biomaterials Networks OS Fenton, JL Andresen, M Paolini, R Langer Angewandte Chemie 130 (49), 16258-16261, 2018 | 41 | 2018 |
| Polymers for extended-release administration MS Paolini, OS Fenton, C Bhattacharya, JL Andresen, R Langer Biomedical Microdevices 21, 1-24, 2019 | 35 | 2019 |
| Outlooks on three-dimensional printing for ocular biomaterials research OS Fenton, M Paolini, JL Andresen, FJ Müller, R Langer Journal of ocular pharmacology and therapeutics 36 (1), 7-17, 2020 | 21 | 2020 |
| Pharmaceutical compositions, preparation and uses thereof A Pottier, M Germain, L Poul, M Paolini, ME Meyre US Patent 11,304,902, 2022 | 20 | 2022 |
| Priming the body to receive the therapeutic agent to redefine treatment benefit/risk profile LLAP Matthieu Germain, Marie-Edith Meyre, Laurence Poul, Marion Paolini ... Scientific Reports, 2018 | 19 | 2018 |
| Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel M Paolini, L Poul, C Berjaud, M Germain, A Darmon, M Bergère, A Pottier, ... International Journal of Nanomedicine, 5537-5556, 2017 | 15 | 2017 |
| Frontier battery development for hybrid vehicles H Lewis, H Park, M Paolini Chemistry Central Journal 6, 1-13, 2012 | 9 | 2012 |
| A new opportunity for nanomedicines: Micellar cytochrome P450 inhibitors to improve drug efficacy in a cancer therapy model M Paolini, L Poul, A Darmon, M Germain, A Pottier, L Levy, E Vibert Nanomedicine: Nanotechnology, Biology and Medicine 13 (5), 1715-1723, 2017 | 4 | 2017 |
| Mononuclear phagocytic system occupancy to increase nanomedicines based treatment efficacy M Germain, L Poul, J Devalliere, M Paolini, A Darmon, M Bergere, ... Cancer Research 79 (13_Supplement), 3613-3613, 2019 | 2 | 2019 |
| Abstract LB-072: Redefine nanomedicine products bioavailability to improve anti-tumor efficacy M Germain, L Poul, ME Meyre, M Paolini, F Mpambani, M Bergere, ... Cancer Research 78 (13_Supplement), LB-072-LB-072, 2018 | 2 | 2018 |
| Hydrogels and uses thereof RS Langer, OS Fenton, J Andresen, M Paolini US Patent 11,491,228, 2022 | | 2022 |
| The Nanoprimer: a nanoparticle designed to transiently occupy the mononuclear phagocytic system in order to increase nanomedicine-based treatments efficacy J Devalliere, L Poul, A Darmon, O Jibault, M Bergere, F Mpambani, ... Cancer Research 80 (16_Supplement), 2871-2871, 2020 | | 2020 |
| Scalable and Tunable Synthetic Hydrogels for Use in Biomaterials Applications OS Fenton, J Andresen, M Paolini, R Langer 2018 AIChE Annual Meeting, 2018 | | 2018 |
| Nouvelles compositions pour l'administration d'agents thérapeutiques: Apport de la nanomédecine pour l'optimisation du ratio bénéfice-risque du traitement M Paolini Université Paris-Saclay (ComUE), 2017 | | 2017 |
Owen S. FentonAssistant Professor of Pharmacy, University of North Carolina at Chapel HillVerified email at unc.edu
